The microbiota-gut-brain axis (MGBA) plays a crucial role in the onset and progression of Alzheimer's disease (AD). Enteric glial cells (EGCs) represent a fundamental cellular constituent that upholds the structural and functional integrity of the MGBA. However, the specific mechanistic role of EGCs in the pathogenesis of AD remains unclear.
Objective
The present study aimed to investigate the synergistic interaction between gut microbiota (GM) dysbiosis and EGCs activation in a mouse of AD.
Methods
Amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic AD mice were utilized as the experimental model. Behavioral experiments, 16S rRNA sequencing, Nissl staining, and immunofluorescence staining were used to evaluate the related changes of AD in cognitive function, neuropathology, GM, and EGCs, respectively.
Results
AD mice exhibited significant cognitive dysfunction, with obvious neuronal damage and Aβ plaques formation in the hippocampus and primary somatosensory cortex. The GM composition of AD mice was significantly altered, α-diversity decreased, and the dominant bacterial population was significantly different from the control group. Morphologically, EGCs in the myenteric plexus (MP) and submucosal plexus (SP) of AD mice were markedly activated, concomitant with a reduction in neuronal count. This alteration in EGCs-neuron interactions was shown to be region-specific in MP and SP.
Conclusions
This study confirms characteristic alterations in GM and abnormal EGCs activation in AD mice, while also uncovering regional specificity of these changes within the enteric nervous system. These findings may provide experimental evidence for the development of targeted intervention strategies for AD based on GM and EGCs.
ScheltensPDe StrooperBKivipeltoM, et al.Alzheimer's disease. Lancet2021; 397: 1577–1590.
2.
LuYFujiokaHWangW, et al.Bezafibrate confers neuroprotection in the 5xFAD mouse model of Alzheimer's disease. Biochim Biophys Acta Mol Basis Dis2023; 1869: 166841.
3.
AlmeidaZLVazDCBritoRMM. Morphological and molecular profiling of amyloid-β species in Alzheimer's pathogenesis. Mol Neurobiol2025; 62: 4391–4419.
4.
JamerlanAMAnSSAHulmeJP. Microbial diversity and fitness in the gut-brain axis: influences on developmental risk for Alzheimer's disease. Gut Microbes2025; 17: 2486518.
5.
HouSYuJLiY, et al.Advances in fecal microbiota transplantation for gut dysbiosis-related diseases. Adv Sci (Weinh)2025; 12: e2413197.
6.
LohJSMakWQTanLKS, et al.Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther2024; 9: 37.
7.
OharaTEHsiaoEY. Microbiota-neuroepithelial signaling across the gut-brain axis. Nat Rev Microbiol2025; 23: 371–384.
8.
YouMChenNYangY, et al.The gut microbiota-brain axis in neurological disorders. MedComm(2020) 2024; 5: e656.
9.
CryanJFO'RiordanKJSandhuK, et al.The gut microbiome in neurological disorders. Lancet Neurol2020; 19: 179–194.
10.
ZhouXPSunLBLiuWH, et al.The complex relationship between gut microbiota and Alzheimer's disease: a systematic review. Ageing Res Rev2025; 104: 102637.
11.
LukiwWJLiWBondT, et al.Facilitation of gastrointestinal (GI) tract microbiome-derived lipopolysaccharide (LPS) entry into human neurons by amyloid beta-42 (Aβ42) peptide. Front Cell Neurosci2019; 13: 545.
12.
KhanMASSLC. Alcohol and the brain-gut axis: the involvement of microglia and enteric glia in the process of neuro-enteric inflammation. Cells2023; 12: 2475.
13.
HouXArtisD. Neuro-immune cell interactions in the regulation of intestinal immune homeostasis. Curr Opin Gastroenterol2025; 41: 38–45.
14.
LiYLiYRJinY, et al.Involvement of enteric glial cells in colonic motility in a rat model of irritable bowel syndrome with predominant diarrhea. J Chem Neuroanat2023; 128: 102235.
15.
SeguellaLGulbransenBD. Enteric glial biology, intercellular signalling and roles in gastrointestinal disease. Nat Rev Gastroenterol Hepatol2021; 18: 571–587.
16.
GonzalesJGulbransenBD. The physiology of enteric glia. Annu Rev Physiol2025; 87: 353–380.
17.
SeguellaLCapuanoRSarnelliG, et al.Play in advance against neurodegeneration: exploring enteric glial cells in gut-brain axis during neurodegenerative diseases. Expert Rev Clin Pharmacol2019; 12: 555–564.
18.
MendonçaIPPeixotoCA. The double-edged sword: the complex function of enteric glial cells in neurodegenerative diseases. J Neurochem2025; 169: e70069.
19.
D'AntongiovanniVPellegriniCAntonioliL, et al.Enteric glia and brain astroglia: complex communication in health and disease along the gut-brain axis. Neuroscientist2024; 30: 493–510.
20.
LiFLiZALiJ, et al.Projection from the parafascicular nucleus of the thalamus to the insular cortex mediate analgesia and anti-anxiety behaviors in mice. Neurobiol2025; 216: 107107.
21.
MendesCEPalombitKTavares-de-LimaW, et al.Enteric glial cells immunoreactive for P2X7 receptor are affected in the ileum following ischemia and reperfusion. Acta Histochem2019; 121: 665–679.
22.
LiYRLiYJinY, et al.Involvement of nitrergic neurons in colonic motility in a rat model of ulcerative colitis. World J Gastroenterol2022; 28: 3854–3868.
23.
DarNJGlaznerGW. Deciphering the neuroprotective and neurogenic potential of soluble amyloid precursor protein alpha (sAPPα). Cell Mol Life Sci2020; 77: 2315–2330.
24.
PfundsteinGNikonenkoAGSytnykV. Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: implications in Alzheimer's disease and normal physiology. Front Cell Dev Biol2022; 10: 969547.
25.
BenilovaIKarranEDe StrooperB. The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci2012; 15: 349–357.
26.
WeaverDF. β-amyloid is an immunopeptide and Alzheimer's is an autoimmune disease. Curr Alzheimer Res2021; 18: 849–857.
27.
WeaverDF. Alzheimer's disease as an innate autoimmune disease (AD): a new molecular paradigm. Alzheimers Dement2023; 19: 1086–1098.
28.
KentSASpires-JonesTLDurrantCS. The physiological roles of tau and Aβ: implications for Alzheimer's disease pathology and therapeutics. Acta Neuropathol2020; 140: 417–447.
29.
EimerWARodriguezASDeFaoMT, et al.Phosphorylated tau exhibits antimicrobial activity capable of neutralizing herpes simplex virus 1 infectivity in human neurons. Nat Neurosci2026; 29: 604–616.
30.
NelsonAR. Peripheral pathways to neurovascular unit dysfunction, cognitive impairment, and Alzheimer's disease. Front Aging Neurosci2022; 14: 858429.
31.
OnisiforouACharalambousEGZanosP. Shattering the amyloid illusion: the microbial enigma of Alzheimer's disease pathogenesis-from gut microbiota and viruses to brain biofilms. Microorganisms2025; 13: 90.
32.
PokrzykJKulczyńska-PrzybikAGuzik-MakarukE, et al.Clinical importance of amyloid beta implication in the detection and treatment of Alzheimer's disease. Int J Mol Sci2025; 26: 1935.
33.
Tarasoff-ConwayJMCarareROOsorioRS, et al.Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol2015; 11: 457–470.
34.
GuoYWangQChenS, et al.Functions of amyloid precursor protein in metabolic diseases. Metabolism2021; 115: 154454.
35.
GallowaySTakechiRPallebage-GamarallageMM, et al.Amyloid-beta colocalizes with apolipoprotein B in absorptive cells of the small intestine. Lipids Health Dis2009; 8: 46.
36.
ChenCZhouYWangH, et al.Gut inflammation triggers C/EBPβ/δ-secretase-dependent gut-to-brain propagation of Aβ and Tau fibrils in Alzheimer's disease. EMBO J2021; 40: e106320.
37.
SunYSommervilleNRLiuJYH, et al.Intra-gastrointestinal amyloid-β1-42 oligomers perturb enteric function and induce Alzheimer's disease pathology. J Physiol2020; 598: 4209–4223.
38.
JinJXuZZhangL, et al.Gut-derived β-amyloid: likely a centerpiece of the gut-brain axis contributing to Alzheimer's pathogenesis. Gut Microbes2023; 15: 2167172.
39.
AgirmanGKBYHsiaoEY. Signaling inflammation across the gut-brain axis. Science2021; 374: 1087–1092.
40.
CattaneoACattaneNGalluzziS, et al.Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging2017; 49: 60–68.
41.
KesikaPSuganthyNSivamaruthiBS, et al.Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease. Life Sci2021; 264: 118627.
42.
VogtNMKerbyRLDill-McFarlandKA, et al.Gut microbiome alterations in Alzheimer's disease. Sci Rep2017; 7: 13537.
43.
WangXWangCLiuK, et al.Association between sleep-related phenotypes and gut microbiota: a two-sample bidirectional Mendelian randomization study. Front Microbiol2024; 15: 1341643.
44.
WangQGaoTZhangW, et al.Causal relationship between the gut microbiota and insomnia: a two-sample Mendelian randomization study. Front Cell Infect Microbiol2024; 14: 1279218.
45.
LiuHGaoPJiaB, et al.IBD-associated Atg16L1T300A polymorphism regulates commensal microbiota of the intestine. Front Immunol2022; 12: 772189.
46.
GuKWuALiuC, et al.Absence of gut microbiota alleviates iron overload-induced colitis by modulating ferroptosis in mice. J Adv Res2025; 76: 233–250.
47.
LiYWangYSunQ, et al.Inhibiting the activation of enteric glial cells alleviates intestinal inflammation and comorbid anxiety- and depressive-like behaviors in the ulcerative colitis mice. Neurochem Int2024; 178: 105789.
48.
HamnettRDershowitzLBSampathkumarV, et al.Regional cytoarchitecture of the adult and developing mouse enteric nervous system. Curr Biol2022; 32: 4483–4492.
49.
DershowitzLBKaltschmidtJA. Enteric nervous system striped patterning and disease: unexplored pathophysiology. Cell Mol Gastroenterol Hepatol2024; 18: 101332.
50.
SharkeyKASavidgeTC. Role of enteric neurotransmission in host defense and protection of the gastrointestinal tract. Auton Neurosci2014; 181: 94–106.
51.
BeckerLNguyenLGillJ, et al.Age-dependent shift in macrophage polarisation causes inflammation-mediated degeneration of enteric nervous system. Gut2018; 67: 827–836.
52.
SaffreyMJ. Cellular changes in the enteric nervous system during ageing. Dev Biol2013; 382: 344–355.
53.
VicentiniFAKeenanCMWallaceLE, et al.Intestinal microbiota shapes gut physiology and regulates enteric neurons and glia. Microbiome2021; 9: 210.
